Cargando…

DLBCL developed into fatal liver failure during rituximab-containing chemotherapy

Detalles Bibliográficos
Autores principales:	Shimazu, Yutaka, Nohgawa, Masaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JSLRT 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661963/ https://www.ncbi.nlm.nih.gov/pubmed/31257349 http://dx.doi.org/10.3960/jslrt.19004

Ejemplares similares

Intradural extramedullary relapse of peripheral T-cell lymphoma, NOS
por: Shimazu, Yutaka, et al.
Publicado: (2020)

Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
por: Oka, Satoko, et al.
Publicado: (2017)

Fatal Case of Enterovirus 71 Infection and Rituximab Therapy, France, 2012
por: Kassab, Somar, et al.
Publicado: (2013)

Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report
por: Monteiro, Rowan, et al.
Publicado: (2017)

Fatal acute hepatorenal failure during antimalarial-based combination treatment
por: Gnionsahé, Apollinaire, et al.
Publicado: (2010)

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL
por: Northend, Michael, et al.
Publicado: (2022)

Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient
por: Jent, Philipp, et al.
Publicado: (2018)

Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era
por: Ha, Hyerim, et al.
Publicado: (2016)

Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
por: Torka, Pallawi, et al.
Publicado: (2022)

Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
por: Cho, Min-Seok, et al.
Publicado: (2016)

Effective maintenance treatment with lenalidomide for a patient with aggressive adult T cell leukemia after chemotherapy
por: Oka, Satoko, et al.
Publicado: (2019)

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53
por: Deng, Manman, et al.
Publicado: (2020)

COVID-19 vaccine failure in a patient on rituximab therapy
por: Chilimuri, Sridhar, et al.
Publicado: (2021)

Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkin's lymphoma patients after rituximab chemotherapy
por: Tsutsumi, Y, et al.
Publicado: (2009)

Rituximab-Related Reversible Hepatocellular Damage
por: Toprak, Selami K., et al.
Publicado: (2012)

Fatal anaphylaxis Due to Nafamostat Mesylate During Hemodialysis
por: Kim, Joo-Hee, et al.
Publicado: (2021)

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
por: Buckley, S A, et al.
Publicado: (2015)

Rhodococcus erythropolis Encephalitis in Patient Receiving Rituximab
por: Bagdure, Satish R., et al.
Publicado: (2012)

Cold autoimmune hemolytic anemia resolved by rituximab
por: Palombi, Massimiliano, et al.
Publicado: (2010)

Minimization of administration route errors with subcutaneous rituximab
por: Liptrott, Sarah, et al.
Publicado: (2016)

Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia
por: Genest, Dominique S., et al.
Publicado: (2021)

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
por: Miyazaki, Kana, et al.
Publicado: (2023)

Pneumothorax during laparoscopic cholecystectomy: A rare but fatal complication
por: Bala, Vinod, et al.
Publicado: (2011)

Fatal venous air embolism during lumbar spondylolisthesis surgery
por: Elouardi, Youssef, et al.
Publicado: (2021)

Who plays the major role in fatal injuries by motorcycle in developing countries?
por: Zarghami, Amin, et al.
Publicado: (2015)

Acute painful lumbosacral paresthesia after intrathecal rituximab
por: Bromberg, J. E. C., et al.
Publicado: (2011)

Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
por: Bai, Xueyan, et al.
Publicado: (2015)

Efficacy and maintenance of rituximab treatment in non‐infectious scleritis
por: Vergouwen, Daphne P. C., et al.
Publicado: (2021)

Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?
por: Brandi, Giovanni, et al.
Publicado: (2020)

Nocardiosis in a renal transplant recipient following rituximab preconditioning
por: Flohr, Tanya R, et al.
Publicado: (2009)

Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
por: Buchegger, Franz, et al.
Publicado: (2011)

Acute Myocardial Infarction after First Dose of Rituximab Infusion
por: Gogia, Ajay, et al.
Publicado: (2014)

A rare case of rituximab induced interstitial lung disease
por: Sahu, Kamal Kant, et al.
Publicado: (2016)

Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal COVID-19: An Observation
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Is primary chemotherapy effective in large hydatid cyst of liver?
por: Gangopadhyay, A. N., et al.
Publicado: (2009)

Fatal pulmonary thromboembolism during total hip replacement under spinal anesthesia
por: Cho, Yong-Hyun, et al.
Publicado: (2013)

A fatal anal impalement
por: Fama’, Fausto, et al.
Publicado: (2016)

Comments on “Fatal colchicine intoxication”
por: Amrollahi-Sharifabadi, Mohammad, et al.
Publicado: (2015)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ajo3u6hm6vhds9rcv34d4rla53